Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Esterase. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103215238A reveals a novel marine esterase PE8 for producing (R)-3-(4-fluorophenyl) monomethyl glutarate, offering a cost-effective enzymatic route for antidepressant intermediates.
Patent CN106119224B reveals high-efficiency esterase for chiral synthesis. Offers mild conditions and supply chain stability for pharma intermediates.
Patent CN112301064A reveals a biocatalytic route for high-purity DV acid. This method simplifies purification and ensures reliable agrochemical intermediate supply.
Patent CN116396950A reveals a novel carboxylesterase mutant for efficient (R)-3-cyclohexene-1-carboxylic acid production, offering superior stereoselectivity and scalable biocatalysis for API intermediates.
Patent CN111057735B details a novel esterase route for high-purity chiral intermediates. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN117535268A reveals high-purity esterase resolution. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalysis.
Patent CN112813131A reveals a high-efficiency carboxylesterase for producing Edoxaban intermediates with superior substrate tolerance and optical purity.
Patent CN110592045B reveals high-purity enzymatic resolution for cardiovascular drug intermediates, offering scalable supply chain solutions.
Patent CN110055297B details a novel esterase for resolving (R,S)-5-caprolactone with >98% ee. Discover cost-effective biocatalytic routes for high-purity flavor intermediates.
Patent CN113201516B reveals a solvent-free enzymatic route for L-menthol with >95% ee. Discover cost-effective manufacturing solutions for high-purity terpene alcohols.
Patent CN113201516A details a novel P-nitrobenzyl esterase mutant for solvent-free L-menthol production, offering superior stereoselectivity and cost-effective manufacturing.
Discover how copper-catalyzed trifluoromethylation enables efficient quinazolinone synthesis for AChE/BuChE inhibition. Reduce production costs and scale complex molecules with CDMO expertise.